1. Alexander C, Andersson HS, Anderson LI, Ansell RJ, Kirsch N, Nicholls IA, O'Mahony J & Whitcome MJ
Molecular imprinting science and technology: a survey of the literature for the years up to and including 2003.
J. Molec. Recogn. 19 (2006) 106-180
2. Armentano F, Knight T, Makker S & Tramontano A
Induction of covalent binding antibodies.
Immunol. Letters 103 (2006) 51-57
3. Azema L, Baron R & Ladame S
Targeting enzymes with phosphonate-based inhibitors: mimics of tetrahedral transition states and stable isosteric ananlogues of phosphates.
Curr. Enzyme inhib. 2 (2006) 61-72
4. Bagshawe KD
Antibody-directed enzyme prodrug therapy (ADEPT) for cancer.
Exp. Rev. Anticancer Ther. 6 (2006) 1421-1431
5. Clark RL, Johnston BF, Suckling CJ & Mackay SP
A modelling study of a non-concerted hydrolytic cycloaddition reaction by the catalytic antibody H11.
Bioorg. Med. Chem. 14 (2006) 2674-2683
6. Dobrodeeva LK, Sen'kova LV, Lyutfalieva GT, Kornienko EB, Prelovskaya IB & Dobrodeev GV
Levels of autoantibodies in healthy subjects.
Human Physiol. 32 (2006) 86-93
7. Egri G & Takats A
Monoclonal antibodies in the treatment of lung cancer.
Eur. J. Surg. Oncol. 32 (2006) 385-394
8. Gabibov AG, Ponomarenko NA, tretvak EB, Paltsev MA & Suchkov SV
Catalytic autoantibodies in clinical autoimmunity and modern medicine.
Autoimmun. Rev. 5 (2006) 324-330
9. Golinelli-Pimpaneau B, Luthi C & Christen P
Structural basis for D-amino acid transamination by the pyridoxal 5'-phosphate-dependent catalytic activity 15A9.
J. Biol. Chem. 281 (2006) 23969-23977
10. Guo F, Das S, Mueller BM, Barbas CF, Lerner RA & Sinha SC
Breaking the one antibody-one target axiom.
Proc. Natl. Acad. Sci. USA 103 (2006) 11009-11014
11. Hifumi E, Yamada Y & Uda T
A catalytic antibody heavy chain HpU-2 degrading its epitope peptide and H. pylori urease.
Immunol. Letters 103 (2006) 68-74
12. Ikhmyangan EN, Vasilenko NL, Buneva VN & Nevinsky GA
Metal ion-dependent peroxidase and oxidoreductase activities of polyclonal IgGs from the sera of Wistar rats.
J. Molec. Recogn. 19 (2006) 91-105
13. Ikhmyangan EN, Vasilenko NL, Sinitsina OI, Buneva VN & Nevinsky GA
Substrate specificity of rat sera IgG antibodies with peroxidase and oxidoreductase activities.
J. Molec. Recogn. 19 (2006) 432-440
14. Karataeva NA, Gorbunov D, Prokudin IV, Buneva VN, Kulminskaya AA, Neustroev KN & Nevinsky GA
Human milk antibodies with polysaccharide kinase activity.
Immunol. Letters 103 (2006) 58-67
15. Kikuchi K, Hannak RB, Guo MJ, Kirby AJ & Hilvert D
Toward bifunctional antibody catalysis.
Bioorg. Med. Chem. 14 (2006) 6189-6196
16. Lacroix-Desmazes S, Wootla B, Delignat S, Dasgupta S, Nagaraja V, Kazatchkine MD & Kaveri S
Pathology of catalytic antibodies.
Immunol. Letters 103 (2006) 3-7
17. Lacroix-Desmazes S, Wootla B,Dasgupta S, delignat S, Bayry J, Reinbolt J, Hoebeke J, Saenko E, Kazatchkine MD, Friboulet A, Christophe O, Nagaraja V & Kaveri SV
Catalytic IgG from patients with hemophilia A inactivate therapeutic factor VIII.
J. Immunol. 177 (2006) 1355-1363
18. Lim PL & Zouali M
Pathogenic autoantibodies: emerging insights into tissu injury.
Immunol. Letters 103 (2006) 17-26
19. Marti S, Andres J, Moliner V, Silla E, Tunon I & Bertran J
Stereoselectivity behavior of the AZ28 antibody catalyzed oxy-Cope rearrangement.
J. Phys. Chem. A 110 (2006) 726-730
20. Matsuura K, Ohara K, Munakata H, Hifumi E & Uda T
Pathogenicity of catalytic antibodies: catalytic activity of Bence jones proteins from myeloma patients with renal impairment can elicit cytotoxic effects.
Biol. Chem. 387 (2006) 543-548
21. Mirshahi M, Shamsipour F, Mirshahi T, Khajeh K & Naderi-Manesh H
A novel monoclonal antibody with catalytic activity against beta human chorionic gonadotropin.
Immunol. Letters 106 (2006) 57-62
22. Mondal K, Ramesh NG, Roy I & Gupta MN
Enhancing the synthetic utility of aldolase antibody 38C2.
Bioorg. Med. Chem. Lett. 16 (2006) 807-810
23. Ponomarenko NA, Durova OM, Vorobiev II, Belogurov AA, Telegin GB, Suchkov SV, Misikov VK, Kiselev SL, Lagarkova MA, Govorun VM, Serebryakova MV, Avalle B, Tornatore P, Karavanov A, Morse HC, Thomas D, Friboulet A & Gabibov AG
Autoantibodies to myelin basic protein catalyze site _ specific degradation of their antigen.
Proc. Natl. Acad. Sci. USA 103 (2006) 281-286
24. Nieva J, Kerwin L, Wentworth AD, Lerner RA & Wentworth P
Immunoglobulins can utilize riboflavin (vitamin B12) to activate the antibody-catalyzed water oxidation pathway.
Immunol. Letters 103 (2006) 33-38
25. Nishiyama Y, Karle S, Mitsuda Y, Tagushi H, Planque S, Salas M, Hanson C & Paul S
Towards irreversible HIV inactivation: stable gp120 binding by nucleophilic antibodies.
J. Molec. Recogn. 19 (2006) 423-431
26. Odintsova ES, Kharitonova MA, Baranovskii AG, Siziakina LP, Buneva VN & Nevinsky GA
DNA-hydrolyzing IgG antibodies from the blood of patients with acquired immune deficiency syndrome.
Mol. Biol. (Moskow) 40 (2006) 857-864
27. Odintsova ES, Kharitonova MA, Baranovskii AG, Sizyakina LP, Buneva VN & Nevinsky GA
Proteolytic activity of IgG antibodies from blood of acquired immunodeficiency syndrome patients.
Biochemistry Moscow 71 (2006) 251-261
28. Olopade CO, Yu J, Abubaker J, Mensah E & Paul S
Catalytic hydrolysis of VIP in pregnant women with asthma.
J. Asthma 43 (2006) 429-432
29. Padiolleau-Lefèvre S, Débat H, Phichith D, Thomas D, Friboulet A & Avalle B
Expression of a functional scFv fragment of an anti-idiotypic antibody with a beta-lactam hydrolytic activity.
Immunol. Letters 103 (2006) 39-44
30. Paul S, Nishiyama Y, Planque S & Tagushi H
Theory of proteolytic antibody occurrence.
Immunol. Letters 103 (2006) 8-16
31. Pauyo T, Hilinski GJ, Chiu PT, Hansen DE, Choi YJ, Ratner DI, Shah-Mahoney N, Southern CA & O'Hara PB
Genetic and fluorescence studies of affinity maturation in related antibodies.
Mol. Immunol. 43 (2006) 812-821
32. Polsukhina DI, Kanyshkova TG, Doronin BM, Tyshkevich OB, Buneva VN, Boiko AN, Gusev EI, Nevinsky GA & Favorova OO
Metal-dependent hydrolysis of myelin basic protein by IgGs from the sera of patients with multiple sclerosis.
Immunol. Letters 103 (2006) 75-81
33. Ponomarenko NA, Durova OM, Vorobiev II, Belogurov AA, Telegin GB, Suchkov SV, Misikov VK, Morse HC & Gabibov AG
Catalytic activity of autoantibodies toward myelin basic protein correlates with the scores on the multiple sclerosis expanded disability status scale.
Immunol. Letters 103 (2006) 45-50
34. Ponomarenko NA, Vorobiev II, Alexandrova ES, Reshetnyak AV, Telegin GB, Khaidurov SV, Avalle B, Karavanov A, Morse HC, Thomas D, Friboulet A & Gabibov AG
Induction of protein-targeted catalytic response in autoimmune prone mice : antibody-mediated cleavage of HIV-1 glycoprotein gp120.
Biochemistry 45 (2006) 324-330
35. Popkov M, Rader C, Gonzalez B, Sinha SC & Barbas CF
Small molecule drug activity in melanoma models may be dramatically enhanced with an antibody effector.
Int. J. Cancer 119 (2006) 1194-1207
36. Rogers CJ, Eubanks LM, Dickerson TJ & Janda KD
Unexpected acetylcholinesterase activity of cocaine esterases.
J. Am. Chem. Soc. 128 (2006) 15364-15365
37. Sagi A, Rishpon J & Shabat D
Amperometric assay for aldolase activity: antibody-catalyzed ferrocenylamine formation.
Anal. Chem. 78 (2006) 1459-1461
38. Shukla GS & Krag DN
Selective delivery of therapeutic agents of the diagnosis and treatment of cancer.
Exp. Opin. Biol. Therap. 6 (2006) 39-54
39. Stan'czak A & Ferra A
Prodrugs and soft drugs.
Pharmacol. Rep. 58 (2006) 599-613
40. Szynol A, De Haard JJW, Veerman EC, De Soet JJ & Van Nieuw Amerongen AV
Design of a peptibody consisting of the antimicrobial peptide dhvar5 and a llama variable heavy-chain antibody fragment.
Chem. Biol. Drug Design 67 (2006) 425-431
41. Takahashi-Ando N, Shimazaki K, Kakinuma H, Fujii I & Nishi Y
Molecular mechanisms of improvement of hydrolytic antibody 6D9 by site-directed mutagenesis.
J. Biochem. 140 (2006) 509-515
42. Uda T, Hifumi E & Okamura Y
Super catalytic antibodies (antigenase) capable of destroying H. pylori urease.
Nippon Rinsho 64 (2006) 286-292
43. Weiss Y, Shulman A, Shir IB, Keinan E& Wolf S
Herbicide-resistance conferred by expression of a catalytic antibody in Arabidopsis thaliana.
Nature Biotechnol. 24 (2006) 713-717
44. Wootla B, Dasgupta S, Mallet V, Kazatchkine MD, Nagaraja V, Friboulet A, Kaveri SV & Lacroix-Desmazes S
Physiopathology of catalytic antibodies: the case for factor VIII-hydrolyzing immunoglobulin G.
Blood Coagul. Fibrinol. 17 (2006) 229-234
45. Zhang K, Zang TZ, Yang W, Sun Y, Mu Y, Liu JQ, Shen JC & Luo GM
Single chain antibody displays glutathione S-transferase activity.
J. Biol. Chem. 281 (2006) 12516-12520
46. Zhu X, Dickerson TJ, Rogers CJ, Kaufmann GF, Mee JM, McKenzie KM, Janda KD & Wilson IA
Complete reaction cycle of a cocaine catalytic antibody at atomic resolution.
Structure 14 (2006) 205-216